Our Pricing

Mounjaro Brough: Expert Weight Loss Support from UK-Registered Pharmacy

Published: 5 October 2026

Residents searching for Mounjaro Brough now have access to tirzepatide weight loss injections through Cured Pharmacy, a fully UK-registered online service offering clinical consultations, genuine licensed medicines, and discreet home delivery across East Yorkshire. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) leads a team of UK prescribers who assess every patient individually, ensuring Mounjaro is clinically appropriate before dispensing. Pricing starts from £124.99, with transparent costs shown before your consultation begins.

Why Brough Residents Choose Mounjaro Through Cured Pharmacy

Patients in Brough seeking Mounjaro benefit from Cured Pharmacy's streamlined online service that combines clinical rigour with convenience. Our platform allows you to complete a full medical assessment in under three minutes from your home, eliminating the need to travel to a physical clinic while maintaining the same regulatory standards required of all UK pharmacies [1]. Every consultation is reviewed by a GMC-registered prescriber who evaluates your BMI, medical history, current medications, and weight loss goals before approving treatment.

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [2]. Clinical trials demonstrated that patients using tirzepatide achieved average weight reductions of 15-22.5% over 72 weeks, depending on dose strength, making it one of the most effective pharmacological interventions currently available for obesity [3]. Our Brough patients appreciate the combination of clinical efficacy and the convenience of home delivery, with all orders dispatched in fully discreet packaging.

How Mounjaro Works for Brough Patients Seeking Weight Loss

Understanding how Mounjaro Brough prescriptions work helps patients set realistic expectations and commit to the treatment journey. Tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, a dual mechanism that enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite [4]. This multi-pathway approach explains why tirzepatide consistently outperforms single-agonist medications in head-to-head trials.

Patients typically begin with a 2.5 mg weekly subcutaneous injection for four weeks, allowing the body to adjust to the medication and minimising gastrointestinal side effects. The dose is then increased incrementally every four weeks—progressing through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum maintenance dose of 15 mg—based on individual tolerance and weight loss response [5]. Our prescribers in Brough review progress at each dose escalation, adjusting the titration schedule if side effects become problematic or if weight loss plateaus.

Expected Timeline for Mounjaro Results in Brough

Most Brough patients notice appetite suppression within the first week of starting Mounjaro, with measurable weight loss typically appearing by week four. The SURPASS-1 trial showed that by week 40, patients on the 15 mg maintenance dose lost an average of 22.5% of their baseline body weight, though individual results vary significantly based on adherence, dietary habits, and baseline metabolic health [3]. We advise patients to combine tirzepatide with a reduced-calorie diet and increased physical activity to optimise outcomes, as the medication works synergistically with lifestyle modifications rather than replacing them.

Mounjaro Brough Pricing and How to Access Treatment

Cured Pharmacy offers Mounjaro to Brough residents from £124.99 per month, with pricing displayed transparently before you begin your consultation. New patients can use code Weightlossnew to receive £20 off their first order, reducing the initial cost to £124.99. This upfront pricing model eliminates hidden fees and allows you to budget accurately for your weight loss journey, which typically spans 12-18 months for optimal results.

Accessing Mounjaro through our service involves three straightforward steps: complete the online medical questionnaire, receive a clinical review from a UK prescriber within hours, and have your medication dispensed from our GPhC-registered pharmacy (9012511) and delivered discreetly to your Brough address. All prescription medications require prescriber approval, and our clinical team may request additional information or suggest alternative treatments if Mounjaro is not appropriate for your individual circumstances. We also offer follow-up consultations at no extra charge to monitor progress and adjust treatment as needed.

Prescription Requirements for Mounjaro in Brough

Mounjaro is a prescription-only medicine in the UK, meaning it cannot be purchased without a valid prescription from a GMC-registered prescriber. Our clinical team assesses eligibility based on NICE and MHRA guidance, which stipulates that tirzepatide should be prescribed for adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities [2]. Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease are typically not suitable candidates. During your consultation, our prescribers will review contraindications, current medications for potential interactions, and your commitment to lifestyle changes that support long-term weight management.

Common Side Effects of Mounjaro for Brough Patients

Like all GLP-1 receptor agonists, Mounjaro can cause gastrointestinal side effects, particularly during the initial weeks and after dose escalations. The most frequently reported adverse events in clinical trials were nausea (affecting up to 30% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort [6]. These symptoms are usually mild to moderate in severity and tend to diminish as the body adapts to the medication. Our Brough patients are advised to eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated to minimise digestive upset.

Rarer but more serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). If you experience severe abdominal pain radiating to the back, persistent vomiting, or signs of an allergic reaction such as rash or difficulty breathing, discontinue Mounjaro immediately and seek medical attention [6]. Our clinical team provides detailed safety information during your consultation and remains available for advice throughout your treatment. Patients in Brough can contact our pharmacist team on (+44) 116 4646009 if they have concerns about side effects or medication administration.

Mounjaro Brough Delivery and Discreet Packaging

Cured Pharmacy dispatches all Mounjaro orders to Brough addresses in completely discreet packaging, with no external markings indicating the contents or the nature of the medication inside. We understand that privacy is paramount for patients seeking weight loss treatment, and our packaging protocols ensure that housemates, family members, or delivery personnel cannot identify the contents. Orders are typically dispatched within 24 hours of prescription approval and arrive via tracked courier within 1-2 working days across East Yorkshire.

Each Mounjaro package contains pre-filled KwikPen injectors, alcohol swabs, and a sharps disposal container, along with detailed administration instructions. The medication must be stored in a refrigerator at 2-8°C and should never be frozen. If you are travelling or unable to refrigerate your pens temporarily, Mounjaro can be kept at room temperature (below 30°C) for up to 21 days. Our pharmacist team provides full storage and injection technique guidance to ensure Brough patients feel confident self-administering their weekly doses.

Reordering Mounjaro in Brough

Patients established on Mounjaro can reorder through their Cured Pharmacy account without repeating the full consultation, though periodic clinical reviews are required to ensure ongoing suitability. We recommend reordering at least one week before your current supply runs out to avoid treatment interruptions, which can reduce efficacy and necessitate restarting the titration schedule from a lower dose. Our system sends automatic reminders to Brough patients when it is time to reorder, and our prescribers review your progress notes to confirm that dose adjustments or additional monitoring are not required before dispensing the next month's supply.

Comparing Mounjaro to Other Weight Loss Treatments Available in Brough

While Mounjaro has demonstrated superior weight loss efficacy in clinical trials, other prescription treatments may be more appropriate depending on individual patient factors, budget, and tolerance. Wegovy (semaglutide) is a single GLP-1 receptor agonist that achieved average weight loss of 15% in the STEP trials, making it highly effective though slightly less potent than tirzepatide [7]. Saxenda (liraglutide) requires daily injections rather than weekly dosing and typically produces 8-10% weight loss, while oral options like Wegovy tablets and Foundayo offer needle-free alternatives for patients with injection phobia [8].

For Brough patients seeking budget-friendly options, Orlistat-based treatments (including Xenical, Alli, and generic Orlistat) work by blocking fat absorption in the gut rather than suppressing appetite, producing average weight loss of 5-7% when combined with a low-fat diet. Our prescribers help patients weigh the trade-offs between efficacy, cost, administration method, and side effect profiles to identify the most suitable treatment. The comparison table below shows how Mounjaro stacks up against other weight loss medications available through Cured Pharmacy for Brough residents.

Scientific References

1. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC. [accessed 5 October 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 5 October 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 5 October 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 5 October 2026]
5. Eli Lilly and Company. (2023). Mounjaro prescribing information. Lilly. [accessed 5 October 2026]
6. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: The SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 5 October 2026]
7. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 5 October 2026]
8. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 5 October 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 5 October 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 5 October 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 5 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.